REG - NatWest Group plc - Director/PDMR Shareholding

NatwestAnnouncement

31/03/2023 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230331:nRSe9411Ua&default-theme=true

RNS Number : 9411U  NatWest Group plc  31 March 2023

31 March 2023

 

NatWest Group plc

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY (PDMRs) in accordance with Article 19 of the Market Abuse
Regulation

 

NatWest Group plc (the Company) announces that the PDMRs set out below
purchased ordinary shares of £1.0769* each in the Company (Shares) (ISIN:
GB00BM8PJY71) on 30 March 2023 at the price indicated, in accordance with the
Company's Chairman and Non-executive Directors shareholding policy (the
Policy):

 Name of PDMR     Position of PDMR        No. of Shares purchased  Price of Shares purchased
 Howard Davies    Chairman                3,853                    £2.671
 Frank Dangeard   Non-executive Director  1,014                    £2.671
 Roisin Donnelly  Non-executive Director  1,014                    £2.671
 Patrick Flynn    Non-executive Director  1,014                    £2.671
 Yasmin Jetha     Non-executive Director  1,053                    £2.671
 Mark Seligman    Non-executive Director  1,053                    £2.671
 Lena Wilson      Non-executive Director  1,014                    £2.671
 The Policy does not appy to Directors scheduled to step down from the Board of
 the Company within the next 12 months.

 

* Note: the nominal value of ordinary shares without rounding is
£1.076923076923077 per share.

The transactions took place on the London Stock Exchange (XLON).

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

For further information contact:-

 

NatWest Group Investor Relations

Alexander Holcroft

Head of Investor Relations

+44 20 7672 1758

 

NatWest Group Media Relations

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSDFSUFEDSESD